Vascular endothelial cell senescence mediated by integrin β4 in vitro  by Liu, Xia et al.
FEBS Letters 581 (2007) 5337–5342Vascular endothelial cell senescence mediated by integrin b4 in vitro
Xia Liua,b, Deling Yinc, Yun Zhangb, Jing Zhaoa,b, Shangli Zhanga,b, Junying Miaoa,b,*
a Institute of Developmental Biology, School of Life Science, Shandong University, Jinan 250100, China
b The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health,
Shandong University Qilu Hospital, Jinan 250012, China
c Department of Internal Medicine, East Tennessee State University, P.O. Box 70622, Johnson City, TN, USA
Received 10 August 2007; revised 25 September 2007; accepted 15 October 2007
Available online 25 October 2007
Edited by Vladimir SkulachevAbstract To understand whether integrin b4 is involved in vas-
cular endothelial cell (VEC) senescence, we examined integrin b4
level changes, as well as P53 and reactive oxygen species (ROS)
levels and alterations of phosphatidylcholine-speciﬁc phospholi-
pase C (PC-PLC) activity before and after knocking-down inte-
grin b4 by small interfering RNA. We found integrin b4, P53 and
ROS levels increased signiﬁcantly, while Ca2+-independent PC-
PLC activity obviously decreased during VEC senescence. On
the other hand, integrin b4 down-regulation attenuated the senes-
cence phenotype and reversed Ca2+-independent PC-PLC activ-
ity, and P53 and ROS levels. The data suggested that integrin b4
might mediate VEC senescence through depressing Ca2+-inde-
pendent PC-PLC and elevating the levels of P53 and ROS.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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As an antithrombotic and anti-inﬂammatory barrier, VEC is
critically involved in the maintenance of vascular homeostasis
in health, through the regulation of vascular tone and integrity
[1]. Recent studies have been shown that VEC senescence plays
pivotal roles in the evolution of age associated cardiovascular
diseases, such as atherosclerosis [2]. The elucidation of mecha-
nism underlying VEC senescence will contribute to provide a
novel therapeutic strategy for vascular disorder.
It has been well established that integrin b4 is implicated in
multiple signaling events, such as cancer invasion, cell apopto-
sis, diﬀerentiation and so on [3–5]. However, most previous re-
searches were focused on carcinomas progression and the
function of this integrin in normal VECs is not well known.
In our previous studies, we found that integrin b4 was involved
in VEC apoptosis and VEC apoptosis was associated with
senescence [4,8]. It has been reported that over expression ofAbbreviations: VEC, vascular endothelial cell; HUVEC, human
umbilical vascular endothelial cells; SA-b-gal, senescence-associated-
b-galactosidase; ROS, reactive oxygen species; PDL, population
doubling level; RNAi, RNA interference; siRNA, small interfering
RNA
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doi:10.1016/j.febslet.2007.10.027integrin b4 promoted young endothelial cell invasion and pro-
moted angiogenesis in the wound and tumor angiogenesis
in vivo [6]. To understand whether integrin b4 is involved in
VEC senescence, we examined the changes of integrin b4 level
with VEC senescence. The results showed that the level of inte-
grin b4 was increased signiﬁcantly during cell senescence. So
we decided to investigate the eﬀect of knockdown integrin b4
on VEC senescence and the possible mechanism by which inte-
grin b4 mediates VEC senescence.
Phosphatidylcholine-speciﬁc phospholipase C (PC-PLC), an
important member of phospholipase C family, played a pivotal
role in age-related signal transduction in human lung ﬁbro-
blasts and rat hepatocytes [7]. Recently, we found that PC-
PLC might be involved in the association of apoptosis and
senescence in VECs [8]. In mammal cells, there are two kinds
of PC-PLC, Ca2+-dependent PC-PLC and Ca2+-independent
PC-PLC [9]. In the study, our focus is on exploring which
PC-PLC is implicated in senescence and whether PC-PLC is in-
volved in the senescence mediated by integrin b4.
It has been well known that P53 plays a key role in senes-
cence in response to diverse stimuli in many cell types, includ-
ing VECs [10,11]. In addition to morphological changes and
senescence-associated-b-galactosidase (SA-b-gal) staining (pH
6.0), increased expression of P53, has been considered as one
of the recognized biomarkers of senescent cells [11]. However,
whether P53 is involved in VEC senescence mediated by inte-
grin b4 is unclear. To address the question, we investigated
the possible relationship between integrin b4 and P53 during
cell senescence.
Reactive oxygen species (ROS) had independently been
implicated in VEC senescence and senescent cells had a higher
ROS level than normal cells, which results in an imbalance of
redox status in VECs [12]. However, whether ROS were impli-
cated in the senescence mediated by integrin b4 remains un-
known.2. Materials and methods
2.1. Cell culture
Human umbilical vascular endothelial cells (HUVECs) were ob-
tained as described previously [13]. Cells were cultured in M199 med-
ium with 10% fetal bovine serum, 2 ng ml1 FGF-2 at 37 C under
humidiﬁed 5% CO2. The experiments were performed on the cells with
a population doubling level (PDL) of 10, 20 or 40.2.2. SA-b-gal staining
VEC senescence is admittedly identiﬁed by SA-b-gal staining [11].
The percentage of positively stained cells was estimated by countingblished by Elsevier B.V. All rights reserved.
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counted at least.
2.3. Western blot analysis
Western blot and the relative protein quantity analysis were per-
formed as described previously [14].
2.4. RNA interference
RNA interference (RNAi) was performed as described previously
[15]. Brieﬂy, senescent VECs were transfected with the speciﬁc human
integrin b4 small interfering RNA (siRNA) oligonucleotides 20–80 nM
(Qiagen, USA) at appropriate time points (24–72 h). Control, cells
were treated with scrambled siRNA (Qiagen, USA). To evaluate the
eﬀect of siRNA-medicated gene silencing experiments, scrambled
siRNA and Rhodamine-labeled siRNA were used as non-silencing
controls, respectively.
2.5. Detection of intercellular ROS level
The levels of ROS were detected by the same method as previously
described [16]. The level of ROS was quantiﬁed with the software of
laser scanning confocal microscope.
2.6. PC-PLC activity assay
PC-PLC activity assay was performed with the method described
before [9].
2.7. Statistical analysis
All experiments were performed in duplicate and repeated three to
ﬁve times. Data are expressed as the means ± S.E. Statistical analysis
was done by t-test. A P value of <0.05 was considered statistically sig-
niﬁcant.Fig. 1. The changes of integrin b4 level during VEC senescence. (A) The ch
percentage changes of SA-b-gal positive cells. $, P < 0.05 vs. #; *, P < 0.01 vs.
assay. (D) The relative quantity of integrin b4 depicted as a bar chart. **, P <
the SA-b-gal positive cells.3. Results
3.1. The level of integrin b4 increased during VEC senescence
In the study, the activity of SA-b-gal was examined in PDL
10, PDL 20 and PDL 40 VECs. As shown in Fig. 1B, the per-
centage of positive cells increased signiﬁcantly during VEC
aging ($, P < 0.05 vs. #; *, P < 0.01 vs. #; *, P < 0.01 vs. $,
n = 3). Based on the results, in the subsequent experiments,
we selected PDL 10, PDL 20 and PDL 40 cells as young and
senescent representatives to study the molecular mechanism
underlying VEC senescence. As shown in Fig. 1D, integrin b4
level in senescent (PDL 40) cells was increased signiﬁcantly
comparing with young cells (**, P < 0.01, n = 5). The data sug-
gested that integrin b4 might be involved in VEC senescence.
3.2. Ca2+-independent PC-PLC activity decreased, but Ca2+-
dependent PC-PLC activity did not changed during VEC
senescence
To know which kind of PC-PLC is involved in senescence,
the activity of PC-PLC was examined in diﬀerent PDL VECs
respectively. As a result, Ca2+-dependent PC-PLC was nearly
not changed, but the activity of Ca2+-independent PC-PLC de-
creased obviously during senescence ($2, P > 0.05 vs. $1; $3,
P > 0.05 vs. $1; $3, P > 0.05 vs. $2; *2, P < 0.01 vs. *1; *3,
P < 0.01 vs. *1; *3, P < 0.01 vs. *2, n = 3) (Fig. 2) The data indi-
cated that Ca2+-independent PC-PLC might be involved in
VEC senescence.anges of SA-b-gal activity in PDL 10, 20 and 40 (a–c) VECs. (B) The
#; *, P < 0.01 vs. $, n = 3. (C) The bands of proteins fromWestern blot
0.01 vs. PDL 10; **, P < 0.01 vs. PDL 20, n = 5. The arrowheads show
Fig. 2. The changes of PC-PLC activity during VEC senescence. Ca2+-
dependent PC-PLC and Ca2+-independent PC-PLC were evaluated in
PDL 10, 20 and 40 VECs, respectively. #2, P < 0.01 vs. #1; #3,
P < 0.01 vs. #1; #3, P > 0.05 vs. #2; $2, P > 0.05 vs. $1; $3, P > 0.05
vs. $1; $3, P > 0.05 vs. $2; *2, P < 0.01 vs. *1; *3, P < 0.01 vs. *1; *3,
P < 0.01 vs. *2, n = 3.
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P53 and ROS have been considered to play important roles
in cellular senescence. As shown in Fig. 3A and B, the level
of P53 increased signiﬁcantly during senescence ($, P < 0.05
vs. #; *, p < 0.01 vs. #; *, P < 0.01 vs. $, n = 3). And the
ROS level was also enhanced during senescence ($, P < 0.01Fig. 3. The changes of P53 and ROS levels in VEC senescence. (A) The band
protein. $, P < 0.05 vs. #; *, P < 0.01 vs. #; *, P < 0.01 vs. $, n = 3. (C) Fluore
(a–c) VECs, respectively. (D) The relative quantity of ROS level. $, P < 0.01vs. #; *, P < 0.01 vs. #; *, P < 0.05 vs. $, n = 3.) (Fig. 3C
and D).
3.4. SiRNA-mediated down-regulation of integrin b4 in
senescent cells
To determine the function of integrin b4 in VEC senescence,
we adopted RNAi strategy to down-regulate integrin b4 in
senescent VECs. Under a laser scanning confocal microscope,
we observed that non-silencing Rhodamine-labeled control
siRNA could enter senescent VECs eﬀectively. Western blot
assay also showed that b-actin siRNA could down-regulated
b-actin obviously, but did not aﬀect integrin b4 (data not
shown). These results showed that the siRNA-mediated gene
silencing experiments in senescent cells were eﬀective.
The results showed that, comparing with scrambled siRNA
(Control) treatment group, integrin b4 siRNA could down-
regulate integrin b4 obviously (Fig. 4A and B). Integrin b4 siR-
NA down regulated this protein markedly in a dose-dependent
and time-dependent manner (Fig. 4C and D) (Fig. 4, **P <
0.01, n = 3).
In subsequent experiments, PDL 40 VECs were used as
senescent cells, 20 nM integrin b4 siRNA was used as the best
concentration, and 48 h was used as the best time point.
3.5. Involvements of P53, ROS and Ca2+-independent PC-PLC
in VEC senescence mediated by integrin b4
In order to understand the involvement of integrin b4 in
VEC cell senescence, the alteration of SA-b-gal activity wass of proteins from Western blot assay. (B) The relative quantity of P53
scent micrographs show the relative level of ROS in PDL 10, 20 and 40
vs. #; *, P < 0.01 vs. #; *, P < 0.05 vs. $, n = 3.
Fig. 4. siRNA-mediated down-regulation of integrin b4 in senescent VECs. (A) The bands of proteins from Western blot assay. (B) The relative
quantity of integrin b4. Control siRNA (control) and b4 siRNA represent proteins from the cells treated with scrambled siRNA (20 nM) or integrin
b4 speciﬁc siRNA (20 nM) for 48 h, respectively. (C) siRNA-mediated down-regulation of integrin b4 in the senescent (PDL 40) VECs is dose-
dependent. Cells were treated with scrambled siRNA, integrin b4 speciﬁc siRNA 20 nM, 40 nM and 80 nM, respectively. (D) siRNA-mediated down-
regulation of integrin b4 is time-dependent, cells were transfected with integrin b4 speciﬁc siRNA 20 nM for 24, 48 and 72 h, respectively. In C and D,
the values of integrin b4 level were determined by Western blot. **P < 0.01 vs. control, n = 3.
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bled siRNA (Control siRNA) or integrin b4 speciﬁc siRNA
(b4 siRNA). As shown in Fig. 5A, the percentage of SA-b-
gal positive cells in integrin b4 siRNA treatment group
(43.84% ± 2.17%) was much lower than that in the control
group (59.65% ± 2.74%) (**P < 0.01, n = 5). The results
showed that down-regulation of integrin b4 suppressed cell
senescence.
As shown in Fig. 5B–E, down-regulation of integrin b4 de-
pressed P53 and ROS levels and inhibited the activity of
Ca2+-independent PC-PLC signiﬁcantly (**P < 0.01;
*P < 0.05, n = 3). The data suggested that integrin b4 might
mediate VEC senescence through regulating P53, ROS levels
and Ca2+-independent PC-PLC activity.4. Discussion
VEC senescence plays an important role in the evolution of
cardiovascular diseases, such as atherosclerosis [2]. However,
the mechanism underlying VEC senescence has not been well
deﬁned.
HUVEC is a good experimental model in vitro to investigate
mechanisms underlying aging processes [8]. SA-b-gal activity is
widely used as a good marker of senescence in some human
cells including HUVEC so far [11], and the telomere length
or telomerase activity is not always changed with VEC senes-
cence [17]. Accordingly, in this study, we identiﬁed the senes-
cent VECs by SA-b-gal activity instead of telomere length or
telomerase activity.It has been known that integrin b4 plays multiple roles in
signal transduction pathways [3,5], but the focus of previous
researches was much on cancer cells, tumorigenesis and angio-
genesis. So far, there is no report on the action of this integrin
in regulating cellular senescence. In this study, we found that
integrin b4 level was increased signiﬁcantly with VEC senes-
cence, and down-regulation of this protein with its siRNA
inhibited senescence obviously. The data suggested that inte-
grin b4 was an important factor in VEC senescence. Addition-
ally, our recent in vivo study showed that the level of integrin
b4 in atherosclerotic lesions was upregulated comparing with
non-atherosclerotic lesions either in apoE/ or C57BL/6J
mice (data not shown). The data suggested that integrin b4
might play an important role in vascular disease associated
with aging.
PC-PLC has been reported to play a pivotal role in cellular
signaling pathways. Previously, we found that PC-PLC was in-
volved in VEC apoptosis signaling and in the association of
apoptosis and senescence in VECs through regulating the lev-
els of P53 and ROS [4,8]. In this study, the results further
showed that, with VEC senescence, Ca2+-independent PC-
PLC instead of Ca2+-dependent PC-PLC decreased obviously,
which resulted in the decline of total PC-PLC activity as previ-
ously reported [8]. Moreover, knockdown integrin b4 in senes-
cent VECs elevated the activity of Ca2+-independent PC-PLC
and partially reversed cell senescence phenotype. The data sug-
gested that integrin b4 and Ca2+-independent PC-PLC were re-
lated in regulating VEC senescence.
P53 functions to transmit senescence signal in many kinds of
cells including VECs. Elevated P53 level promotes the onset of
Fig. 5. P53, ROS and PC-PLC were implicated in integrin b4-mediated VEC senescence. (A) siRNA-mediated down-regulation of integrin b4
suppressed VECs senescence. **P < 0.01 vs. control siRNA, n = 5. (B) The bands of proteins from Western blot assay. (C) The relative quantity of
P53. (D) Eﬀect of integrin b4 siRNA on ROS level. (E) Eﬀect of integrin b4 siRNA on Ca2+-independent PC-PLC activity. Senescent cells were
treated with integrin b4 siRNA 20 nM for 48 h. **P < 0.01 vs. control siRNA; *, P < 0.05 vs. control siRNA, n = 3.
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phenotype [10,11,18]. Interestingly, p53 can regulate the intra-
cellular redox state, which was associated with ROS, another
important modulator of cell senescence [19]. Here, our results
showed that down regulating integrin b4 suppressed the in-
crease of P53 level induced by senescence. The data indicated
that integrin b4 might mediate VEC senescence through P53.
Accumulated evidence has demonstrated that ROS act as
important signals in VEC senescence [8,12]. Endothelium
aging was usually accompanied with enhanced ROS level,
which might be a potential biomarker of cell senescence. In this
study, we oﬀered the new evidence that knockdown integrin b4
could reverse the ROS level of senescent VECs, in concomi-
tance with the inhibition of cell senescence. The data suggested
that integrin b4 might mediate VEC senescence in association
with ROS.
It has been reported that Ras and PI-3K are implicated in
integrin b4 signaling pathways [20,21]. Accumulating evidence
suggests that Ras was involved in cell senescence. Activation of
the Raf-MEK-ERK pathway by oncogenic Ras leads to pre-
mature senescence by stimulating the activity of the p38 path-
way, which is suﬃcient to induce the accumulation of p53 [22].
In the present study, we found that down-regulating integrin
b4 suppressed the increase of P53 level induced by senescence.
Whether the decreased P53 level induced by down-regulation
of integrin b4 is through Ras cascade signaling remains to be
further studied. Kristin et al found that the PI3K/Akt pathwayplays an important role in VEC senescence through regulating
telomerase activity [23]. Whether PI3K/Akt acts as a down-
stream target of integrin b4 in VEC senescence signal pathway
remains to be investigated in our next studies.
Previous reports have shown that integrin b4 is involved in
NF-jB signaling in mammary tumors [24]. Recently, NF-jB,
a redox-sensitive transcription factor, is reported to play an
important role in the aging process. Increased ROS promotes
endothelial NF-jB activation and NF-jB may contribute to
endothelial oxidative stress associated with aging [25,26]. In
this study, we found that ROS level was decreased signiﬁcantly
when integrin b4 was knockdown, indicating that ROS were
implicated in integrin b4-mediated VEC senescence. The rela-
tionship between NF-jB and integrin b4 in VEC senescence
needs to be investigated.
In summary, our present study provided the new evidence
as follow. First, the level of integrin b4 was increased signif-
icantly in senescent VECs. Second, down-regulation of inte-
grin b4 inhibited VEC senescence, simultaneously, the
changes of Ca2+-independent PC-PLC activity and the levels
of P53 and ROS resulting from senescence were also partially
overturned. Taken together, the data suggested that integrin
b4 might mediate VEC senescence through depressing Ca2+-
independent PC-PLC and elevating the levels of P53 and
ROS.
Our ﬁndings provided new clues for illustrating the molecu-
lar mechanism of VEC senescence and encouraged us to
5342 X. Liu et al. / FEBS Letters 581 (2007) 5337–5342elucidate the association between integrin b4 and cell senes-
cence in next studies.
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